For years now investors have “plowed” their savings into the stock market, believing that stocks outperform other securities over the long term, said Peter Coy in BusinessWeek. That’s not wrong. But “what many investors have failed to realize …
Amicus Therapeutics, Inc. FOLD was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
Europe's major stock markets churned lower Wednesday as investors took ... Bitcoin is down from record highs approaching $20,000 in the week before …
12/14 Amicus Therapeutics Submits New Drug Application to U.S. FDA for Migalastat f.. 12/14 BRIEF-Amicus …